Dean Koh

This follows the Singapore-based startup’s undisclosed amount of Series B funding in January 2020.

Telehealth, including the use of remote consultation, can improve cost optimization of healthcare resources, and engage the population in early prevention and management of chronic conditions.

The company targets to launch its SPECTRA IMDx system in Europe and selected countries in Asia in 2021.

Wysa’s chatbot uses CBT and engages users in meditation, breathing yoga and aims to help people build resilience skills.

Researchers from SMART’s AMR IRG, NTU and MIT are working together to develop a rapid serological test and a rapid diagnostic test (RDT), based on protein detection.  

The company is building the world's largest RWE platform in behavioral health and chronic diseases to expand data-driven, evidence-based care for people managing behavioral health conditions.

Professor Wang Linfa, Director of the Duke-NUS’ Emerging Infectious Diseases programme, and team conceived this research and invented the cPass diagnostic test.

Singapore-based HeartVoice, which was formed in February 2019 as a joint venture between both iAPPS and Omron Healthcare, announced last week that it will extend the use of its telehealth platform to all healthcare providers for free in the country until 31 July, 2020.

HealthAssure aims to serve the healthcare needs of more than 5 million people in India by the end of this year.

In addition to the funding, CXA Group has signed a MoU with Humanica to integrate its Human Capital Management platform with their platform in Thailand.